Lv71
4118 积分 2022-08-01 加入
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
18天前
已完结
Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice
18天前
已完结
First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors
20天前
已关闭
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
2个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
2个月前
已完结
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
2个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Fundamentals of Clinical Trials
3个月前
已关闭
Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial
4个月前
已完结
Incidence of antibody–drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis
4个月前
已完结
皖公网安备34019202002308
